Nurses are well positioned to stop dangerous and costly bloodstream infections caused by the improper placement of catheters in large veins in the neck, chest or groin, according to guidelines released by the Joint Commission, which oversees accreditation for U.S. hospitals, nursing homes and other healthcare facilities. Central line-associated bloodstream infections (CLABSI) needlessly afflict thousands of patients each year, lengthening hospital stays, boosting hospital readmission rates, and driving up the cost of care.
These devastating bloodstream infections dont need to happen, says Patricia Stone, PhD, MPH, RN, FAAN, the Centennial Professor of Health Policy in Nursing at Columbia University School of Nursing. Stone contributed to the best-practice guidelines issued by the Joint Commission and has published extensive research on the prevention of bloodstream infections.
Nurses are on the front lines and can take advantage of their constant contact with patients and other caregivers to explain infection control techniques and help health facilities develop and enforce standards of care that have been proven effective against CLABSI, she says.
Catheters deliver life-saving medicines and nutrients to some of the most vulnerable patients including premature babies in intensive care units, adults recovering from major trauma and surgery, and frail elderly patients in long-term care settings. Without proper insertion, utilization, and maintenance, catheters can also transmit deadly infections to the bloodstream.
Nurses, using their infection control training, play a vital role in creating a culture of patient safety, Stone says. They often help organize and implement effective prevention techniques including catheter insertion checklists, regular replacement of dressings, and proper handwashing techniques. With their background in education, nurses have the knowledge to inform patients and colleagues about evidence-based practices to reduce CLABSI.
Each year in the U.S., there are an estimated 100,000 deaths from healthcare-associated infections, and one third of the fatalities are from CLABSI, according to the Joint Commission.
Healthcare-associated infections create approximately $33 billion in excess medical costs for U.S. hospitals every year, yet it isnt clear how to ensure that best-practices for prevention are followed, Stone found in a review of programs in place at acute-care hospitals that was presented earlier this year at IDWeek, a conference dedicated to research in prevention, diagnosis, treatment and epidemiology of infectious disease. While most hospitals have infection prevention policies, adherence can be haphazard, putting patients at risk, Stone found.
These infections drive up healthcare costs, wasting resources that could be spent meeting so many other patient needs, Stone says. The Joint Commissions guidelines underscore the value of investing in nurses and making sure caregivers at the bedside have all the resources they need to keep patients safe.
Source: Columbia University School of Nursing
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.